MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be ...

MENLO PARK, Calif. - Pacific Biosciences of California, Inc. (NASDAQ: PACB), known as PacBio, announced the appointment of Jim Gibson as its new Chief Financial Officer, set to start on March 31 ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent fourth-quarter results, is expected to ...

Sequencing solutions provider Pacific Biosciences of California (NASDAQ:PACB) announced on Thursday the appointment of Jim Gibson to the post of CFO, effective March 31. Gibson joins from Sequoia ...

MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be ...

MENLO PARK, Calif. - Pacific Biosciences of California, Inc. (NASDAQ: PACB), known as PacBio, announced the appointment of Jim Gibson as its new Chief Financial Officer, set to start on March 31, 2025 ...

As revealed via Variety, the exciting sequel, titled The Resurrection of the Christ, has officially penciled in its production start date, with Rome’s Cinecittà Studios ready to host the ...

“The Passion of the Christ” will resurrect this summer. Mel Gibson’s long-awaited sequel, titled “The Resurrection of the Christ,” will start shooting in August at Rome’s Cinecittà ...

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by analysts at Scotiabank from $6.00 to $2.00 in a research note issued on Tuesday,Benzinga reports.